outre-mer – Lancement des essais cliniques de l'Heberprot-P en outre-mer

This written question concerns the launch of clinical trials for the drug Heberprot-P in France's overseas territories. It seeks information on the progress and implications of these trials. The question affects patients and healthcare providers in overseas territories, potentially impacting access to new treatments and the development of medical research in these regions.